HIGHLIGHTS
- who: Ruo-Xi Wang from the University of California, Davis, United States have published the article: SDF-1 expression and tumor-infiltrating lymphocytes identify clinical subtypes of triple-negative breast cancer with different responses to neoadjuvant chemotherapy and survival, in the Journal: (JOURNAL)
- what: The authors analyzed the correlation of SDF-1 and TILs at different time points during NAC and aimed to demonstrate the predictive and prognostic performance of SDF-1 in chemonaive and chemo-resistant TNBC. The authors demonstrated that serum SDF-1 serves as a biomarker for predicting the treatment response and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.